Production method of halogen n-/mepkaptoacyl/proline derivatives
2 claims: 2 independent, 0 dependent
- 1PŘEDMĚT VYNÁLEZU 1. Způsob výroby halogenovaných derivátů N-(merkeptoacyl)prolinu, obecného vzorce X (I)· R-S-(CH) n -CH-CO-N------------CH-COOR, ve kterém R znamená atom vodíku nebo alkanoylovou skupinu se 2 ež 4 atomy uhlíku, n má hodnotu 0 nebo 1 , R^ znamená atom vodíku nebo alkylovou skupinu s 1 až 4 atomy uhlíku, každý ze symbolů R 2 a R^ představuje atom vodíku nebo halogenu, n 3 znamená atom vodíku, alkylovou skupinu s 1 až 4 atomy uhlíku nebo trifluormethylo- vou skupinu, přičemž v případě, že д má hodnotu 1, R^ znamená rovněž atom halogenu a / R^ představuje atom vodíku, alkylovou skupinu s 1 až 4 atomy uhlíku nebo trifluormethylovou skupinu, s tím, že alespoň jeden ze symbolů R 2 , R 2 , a R^ znamená atom halogenu nebo trifluormethylovou skupinu, v souhlase se shora uvedenými významy těchto symbolů, přičemž pouze Rg a R 2 mohou oba současně znamenat atom halogenu, a jejich solí s bázemi, vyznačující se tím, že se kyselina obecného vzorce II (II), ve kterém R, R 3» R 4 a — nají shora uvedený význam, kondenzuje s aminokyselinou obecného vzorce III h 2 c ch 2 (III), HN-----------CH-COOR 1 ve kterém R|, R 2 a R^ mají shora uvedený význam, výsledný produkt obecného vzorce I, ve kterém R znamená alkanoylovou skupinu se 2 až 4 atomy uhlíku a zbývající obecné symboly mají shora uvedený význam, se popřípadě hydrolýzuje na odpovídající produkt, v němž R znamená atom vodíku a/nebo se výsledná sloučenina popřípadě převede působením báze na svoji sůl s bází.
- 2Způsob podle bodu 1 к výrobě sloučenin,obecného vzorce Ia ve kterém (Ia), R, R i n nají význam·jako v bodu 1, každý ze symbolů R2a i R2a · znamená atom vodíku nebo fluoru» Rja v případě, že n má hodnotu 0, představuje triluoomiethylovou skupinu i v případě, že n má hodnotu 1 , představuje jeden ze symbolů Rj i Rga trifuuoraethyllvos skupinu i druhý znamená atom vodíku, i jejich solí s Oázemi, vyzn^čujcí se tím, že se jako výchozí látky mooSití sloučeniny obecných vzorců Ila i lila R-S-(CH)n-CH-COOH H O C CH, (Ila) (IKe), HN----------CHcOOJRj z nichž R, R, о» К 21’ R2a* Rja ' i R ga mmaí v tomto Oudu uvedený význam.
Independent claims2
144 paragraphs, as filed
Particularly preferred are those compounds of formula I in which the hydrogen or C 2 -C 4 alkanoyl group, in particular hydrogen or acetyl, represents a hydrogen atom or a C 1 -C 4 alkyl group, in particular a hydrogen atom. .
in each case hydrogen or halogen, in particular hydrogen or fluorine, in each case represents a hydrogen atom, a trifluoromethyl group or an alkyl group. . C 1 -C 4 carbon atoms, wherein in the case of. and R8 is a hydrogen atom, one of R1 and R1 is trifluoromethyl and the other of which is hydrogen, and has a value of 0 or 1, in particular 1.
Managed by the preferred configuration for the above prines is the L-configuration ·
The above-defined alkyl groups are straight or branched chain hydrocarbon radicals, from methyl to ethyl, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl. Preferred are those groups mentioned above containing 1 or 2 carbon atoms.
The aforementioned alkanoyl groups are to be understood as meaning the acyl radicals of lower C 2 -C 4 fatty acids, such as, for example, acetyl, propionyl, bityrole, isobutyryl and the like. Acetyl is particularly preferred.
By halogen atoms is meant all four conventional halogens, of which chlorine, bromine and fluorine, especially fluorine, are preferred.
Compounds of formula (X) above may be prepared by a variety of synthetic procedures.
In general, these compounds can be prepared by reacting the compounds of formula XX
<img file="CS230562B2_D0001.tif" />
RS- (CH)<sub>n</sub>-CH-COOH (XX) is condensed with an amino-acid of formula XXX <sup>H</sup>2\ /<sup>2 </sup>/4
No.<sub>2</sub>с CH<sub>2</sub>
HN-CHCCOC4 (III) by any method that can be used to form amide bonds [see, for example, der Organischen Chemie (Houbsn-Weyl), part X,. 376 et seq., part část, page 1 et seq (1974)).
The acids of formula H in which n has a value of 1 can be obtained by addition of a thiocyanate of formula
R-SH to a suitably substituted acrylic acid. For the temporary protection of the mercaptoacin in the compounds of the formula (I), a p-methenoxybutyl radical R may be used. This group is then removed by treatment with trifluoroacetic acid and mercuric acetate. The gels of the general formula H1. wherein δ is 0 to be prepared by an exchange reaction using an acid of the formula R-SH and 2-halo-methyl.
When R in the starting material of the formula XI is an alkanoyl group having 2 to 4 carbon atoms, they are obtained by the above reaction of a compound of the formula V
<img file="CS230562B2_D0002.tif" />
COOR, (V), wherein alk is a (C 1 -C 3) alkyl group which can then be converted by conventional alkaline hydrolysis or anonolysis. can be converted to the corresponding compounds of formula VI
<img file="CS230562B2_D0003.tif" />
COOR, (VI).
In the case where R 1 represents an ester residue (i.e., when R represents a C 1 -C 4 alkyl group which is present in the product when the starting acid of the formula III is used in the ester form), it is possible to this ester residue is cleaved in a conventional manner. Thus, for example, when R 1 is a tert-butyl group, it is obtained by reacting an ester of formula (V) or (VI) with trifluoroacetic acid and an anisole in addition to the free acid. In the case of other alkoryl groups, the corresponding acid is obtained by basic hydrolysis.
When the starting material is an acid of formula (III) or the resulting product in the form of free carboztylic acid, it can be converted to the ester, for example by esterification with diazoalkane, such as diazomethane, 1-alkyl 1-3. - .beta.-trichloro-azene, such as 1-o-tert-butyl-3-ylglyltrezeoe, and the like;
According to a variant of the process according to the invention, the ester of the formula III, preferably the meetyl or tert-butyl ester, is treated in an anhydrous environment, such as dichloromethane, tetrahydrofuran, dioxane and the like, with an acylthioaccanoic acid of the formula VII.<sup>4 - |3</sup> alk-CO-S- (CH) n-CH-COOH (VII) in the presence of dicyclic hexyltrimide, N, N'-carbonylbisimidazole, ethorylacetylene, diphenylphosphorylcidide or the like, at a temperature in the range of about 0 to 10 ° C . The ester group can then be removed, for example by treatment with trifluoroacetic acid and anisone at a temperature around room temperature, to give the corresponding free acid (R1 = hydrogen).
In accordance with a further moodfication, preferably when n is 1, R1 is a trifluoromethyl group and R1 is a hydrogen atom, the acid of the formula akk-CO-SH is reacted with an acrylic acid derivative of the formula VIII.
<img file="CS230562B2_D0004.tif" />
(VVII), - COOR, <sub>η</sub><sup>н</sup>о<sup>с</sup> i J Uι
I liI
CH = C-C -N and then proceed as described above.
Compounds of formula VIII are prepared from 3-trifluoroethylacrylic acid and an ester of formula III as described in Example 1 below.
Halogen compounds of formula (III) which are used as starting materials can be prepared by known methods [see, for example, Biochemistry 6, 2509 (1965), Amt. J. Chem., £ 0, 1493 (1967), J. Arner, Chem., Soc. 6, 4709 (1964); J. Med. Chem. 20, 1176 (1977)].
The products of formula I produced contain one or more centers of asymmetry. Accordingly, the compounds of formula I may exist in stereoisomeric forms or in recombinant mixtures thereof. All of the above forms are within the scope of the invention. In the synthetic procedures described above, the racemate or one of the enantiomers may be used as the starting material. When the racemate is used as the starting material for the synthesis, the resulting product can be resolved into stereoisomers by conventional chromatographic techniques or by freeze-drying. The preferred isomeric form is generally the L-isomer (with respect to the basic center of the asylene).
The compounds produced by the process of the invention form salts with various inorganic and organic bases, which salts are also within the scope of the invention. Such salts include ammonium salts, alkali metal salts such as sodium and potassium salts (these salts are preferred), alkaline earth metal salts such as calcium and magnesium salts, salts with organic bases such as dicyclohenyrlamine, benzathine, N-mmt γ-D-glucamine and hydrabamine, salts with amino acids such as arginine, lysine and the like. Preferred salts are non-toxic, physiologically acceptable salts, but other salts are also useful, for example, for isolating or purifying products.
The aforementioned salts are prepared in a conventional manner by reacting the free acid product with one or more equivalents of the appropriate base to give the desired cation in a solution.<sup>p</sup>ou<sup>at</sup>body or environment in which the salt is insoluble;<sup>b</sup>o ve vo<sup>dě</sup> followed by dissolving the water by filtration by non-ironization of the salt with an insoluble acid, such as a β-cycle ion exchanger (for example with a polystyrenesulfonic acid such as Dowex 50) or with an aqueous acid, with extraction with an organic solvent such as ethyl acetate; and the like, the free acid can be recovered and optionally converted to another salt.
Further experimental details are set forth in the Examples, which are preferred embodiments and also serve as modal processes for preparing other compounds of the invention.
The compounds of the invention are useful as typotensive agents. These compounds inhibit the conversion of the decapeptide α-β-β-I to engiotenein II and are therefore useful for suppressing or alleviating hypertension caused by anglotensin. Angiotensin I is produced by the action of the enzyme renin, not angiotheresis, which is pseudoglottinHn in blood plasma.
Angiotensin I is converted to angiotensin II by the action of the angiotensin converting enzyme (ACE). The latter compound is an active hypertension which causes various forms of hypertension in various mammalian species, such as rats and dogs.
The compounds of the invention interfere with the angiotensinogen process, -> (renin) -> angiotensin I -> (АСЕ) - ^ angiotensin II, by inhibiting the enzyme АСЕ and suppressing or eliminating the formation of the angiotensin II pressor. Administration of compositions comprising one or more compounds of Formula I, or physiologically acceptable salts thereof, ameliorates angiotensin-induced hypertension in a mammal suffering from the disease.
The result of the modeled animal tests described by SL Engel, TR Schaeffer, Μ. H. Waugh and B. Rubin [Proc. Soc. Exp. Biol. Copper. 143. 483 (1973)], a suitable single dose, or preferably two to four sub-daily doses, in an amount of 0.1 to 100 mg of active ingredient per kilogram of body weight per day, preferably about 1 to 50 mg, is suitable for lowering blood pressure. kg / day ^
The active compounds according to the invention are preferably administered orally, but can also be administered parenterally, such as subcutaneously, intramuscularly, intrevenously or intraperitoneally.
The compounds of the invention may be used to lower blood pressure in the form of compositions, such as tablets, capsules or elixirs for oral administration, or sterile solutions or suspensions for parenteral administration.
Tzv. A unit dose, commonly known in pharmaceutical practice, comprises about 10 to 500 mg of a compound or mixture of compounds of Formula I or their physiologically acceptable salts, in combination with a physiologically acceptable carrier, binder, preservative, stabilizer, flavoring, or other auxiliary substance. Said compositions contain an amount of active ingredient such that a suitable dosage will be obtained within the above range when administered.
Examples of excipients which may be used in the preparation of tablets, capsules and the like include binders such as trangant, acacia, corn starch or gelatin, diluents such as calcium phosphate or microcrystalline cellulose, disintegrating agents such as corn starch , potato starch, alginic acid and the like, glidants such as magnesium stearate, sweeteners such as sucrose, lactose or saccharin, flavoring agents such as peppermint oil, oil of wintergreen or cherry flavor.
When the unit dosage form is a capsule, it may contain, in addition to materials of the above type, a liquid carrier such as a fatty oil. Various longer materials may be used to coat or otherwise modify the physical form of the unit dose.
For example, tablets may be coated with shellac, sugar, or both. Syrups or elixirs may contain the active ingredient, sucrose as a sweetener, methyl and propylparabens as preservatives, coloring and flavoring agents such as cherry or orange flavor.
Sterile injectables may be prepared by conventional pharmaceutical procedures by dissolving or suspending the active ingredient in a vehicle such as water for injection, natural vegetable oils such as sesame oil, cocoa oil, peanut oil, cottonseed oil and the like.
The invention is illustrated by the following non-limiting examples. These examples describe particularly preferred embodiments.
Example 1
1- (4,4,4-Trifluoro-2-butenoyl) -L-proline
In a 50 ml flask equipped with a Dean-Stark trap, 7.0 g (0.1 mol) of boric anhydride (prepared by melting boric acid in a platinum crucible and comminuting under nitrogen) was mixed with 32.2 g (0.173 mol). of ethyl 3-hydro-3,4,4-trifluorobutenoate and the mixture was heated in a salt bath until all the anthrydride had dissolved (6 hours). The temperature is raised to 350 ° C, 23 ml of distillate are collected in the well. The dessilate is returned to the reaction flask and the aforementioned gaze - repetition. This procedure was repeated four times to ensure complete dehydration with the hydrosulfate.
The dilatate is pelletized in petooletheum, dried over phosphorous phosphate and distilled. 10 g of ethyl acetate are obtained<sup><</sup>22-Buenoic acid (b.p. 115-120 ° C) and 650 mg 4,4,4-trifluoro-lenoic acid (van 150 ° C, m.p. after crystallization from pentane 53-55 ° C).
The ester was mixed with 24 ml of -0% aqueous sodium hydroxide, stirred at 25 ° C for 6 hours, then diluted with water and extracted with ethyl acetate to remove unreacted material. Aqueous layer with concentrated hydrochloric acid. The mixture was extracted three times with 50 ml of methylene chloride each time.
The organic layers were combined, dried over sodium sulfate, concentrated and distilled. Crystalline 4,4,4-trifluoro-2-lueic acid having a van temperature of 145-153 ° C is obtained. After recrystallization from pentane, the acid melts at 54-55 ° C. Yield 4.6 g.
A mixture of 4.91 g (35 mmol) of 4,4,4-trifluoro-2-lysinic acid, 4.73 g (35 mo) of hydroxybenzotriazole, 6.00 g (35 mmol) of L-proline tert -butylssteol and 7. 22 g (35 ml) of dicyclohexylcarbodiioid are stirred in 200 ml of ethyl phosphate overnight under nitrogen at room temperature. '
The resulting mixture is filtered, the filtrate is washed twice with 50 ml each of 5% sodium hydrogen sulphate and twice with 50 ml each of saturated sodium bicarbonate solution, dried over sodium sulphate and concentrated. The oily residue is taken up in ether, the solution is cooled and the precipitate formed is filtered off.
Concentration of the IR gives 8.7 g of a solid, m.p. 95 DEG-100 DEG C., which, on thin layer chromatography on silica gel, in a solvent system of ethyl acetate-dichloromethane (1: 1), gives a single spot of Rf = 0.85.
4.0 g (13.6%) of the above-prepared 1- (4,4,4-trifluoromethyl-2-butynoyl) -L-proline tert -butylettene with 60 ml of trifluoroacetic acid and 13 ml of enol The mixture was stirred under nitrogen for 1 hour. The roasters were evaporated at age, the residue was dissolved in 10 ml of ether and poured into 500 ml of foam. ,
This precipitation is repeated and the residue is allowed to stand at 0 ° C for 72 hours while undergoing step-thylation. After recrystallization from a mixture of stylyl acetate and hexane, 1- (4,4,4-oxo-22-biphenyl) -L-ol is obtained, m.p. 119-120 ° C. Siní extract 2,4β g.
Example 2
- (- mercapto-1,4,4-trifluoromethyl) -L-proline
1.5 ml of acetic acid was added to -20 mg ((3 mol of 1 - ((, 4,4-trifluoro-2-lutengyl)) in an atmospheric atmosphere. The mixture was stirred overnight at room temperature and excess acetic acid was evaporated in vacuo and the remaining 1- (3-tert-ethylthio-4,4,4-triazoloblotyl) (-L-prolonged with ethyl acetate). Aqueous ammonia (15 ml concentrated ammonia + 15 ml water).
The mixture was stirred at room temperature for 2 hours, then diluted with ice and washed with concentrated hydrochloric acid. The acidic mixture was extracted with ethyl acetate (3 x 50 ml), dried over sodium sulfate and concentrated. The oily residue was dissolved by dissolving in water (used - osdestigative water), clarifying the solution with activated charcoal and filtering through a millipore filter (0.4 β then 0.08 m). 3-mercapt-3-mercapto-trifluorobutanoyl-L-proline in the form of a glassy product · Rf = 0.24 [benzene-acetic acid (7: 1)] ·
Example 3 cis-1- [D-3- (acetylthio) -2-methylpropanoyl] -4-flbor-L-proline
4.5 g (0 & apos;; 021 & apos; eol) of cis [beta] - [beta] - [beta] -L-proline hydrobromide and 4.2 g (0.023 mol) of D-3-acetylthi) 22 & apos; 20 minutes of reaction in 50 ml of water in the presence of sodium carbonate to maintain a pH of 8.0 to 8.2 during the acylation. After a further hour, the mixture is washed twice with 50 ml of ethyl acetate, overlaid with ethyl acetate, propyl and hydrochloric acid to pH 2, saturated with sodium chloride and the layers are separated.
The aqueous phase was not extracted with further ethyl acetate, the organic layers were combined and evaporated after drying. The solid residue after evaporation of ethyl acetate and under ether was triturated and evaporated again. 146 g (93%) of a colorless product, m.p. 146 DEG-148 DEG C. (sintered at 133 DEG C.) and optical rotation [.alpha.] @ -132 DEG (c = 1; methane).
Addition of dicyclohexylamine to cis-1- [D-3] (acetylthi) -2-methylpropano [1,242] fl.<sub>Γ</sub>) .L2p<sub>Γ</sub>of dicyclohexylammonium salt was prepared in 70 ml of ethyl acetate. 8.1 g of salt were obtained, which emerged from the mixture and had a melting point of 202 to 204 ° C (sintered at 187 ° C) and optical rotation. <sup>[α]</sup>ρ<sup>6</sup> -<sup>72</sup>° <sup>(</sup>c = <sup>1;</sup> methtno<sup>and</sup>).
After covering from 90 ml of 180 ml of propyl alcohol, 7.0 g of product are obtained, m.p. 205-207 ° C. <sup>1</sup>9<sup>0</sup> °<sup>C)</sup> a ^ strike rotocifa] ^ = -<sup>7</sup>4 ° · Pattern<sup>to</sup> for<sup>d</sup>uktu nezkazuj<sup>E </sup>No change in melting point or optical rotation after recrystallization from ethanol ·
16.9 g of the cyclotexylammonium salt are converted back to the free acid by shaking between 10% potassium borohydride and ethyl acetate (60 ml of a 10% potassium hydrogen chloride solution and four extractions each with 50 ml of ethyl acetate). The organic layers were combined and evaporated to dryness to give 4.1 g (71%) of a colorless free acid, mp 154-156 ° C (sintered at<sup>1</sup>40 °<sup>C)</sup> ao<sup>p</sup>^<sup>and</sup>[α] D = -142 ° <sup>(</sup>c = 1; me<sup>E</sup>htao<sup>and</sup>).
EXAMPLE 4 • C24-C24ffboo211- (2-2-methyl-2-methylpropanoyl) -L-propanol
3> 9 g (0.014 mol) of cis-1- [D-3-acetylthiol]<sup>p</sup>eooyO] 242fuccπ2L2prilinb is hydrolyzed in 22 ml of water containing! 9 ml of concentrated ammonium hydroxide. The reaction mixture was crystallized with hydrochloric acid and extracted with ethyl acetate. Concentration of the organic layer to dryness yielded 3.3 g of a glassy product which, when dried at 50 DEG C. under a pressure of 27 Pa, slowly melted to the cover. triturated with 20 ml of ethyl acetate under gentle heating under argon, diluted with 25 ml of hexane and, after trituration, cooled to room temperature overnight. argon ·
Filtration under argon, washing with hexane and drying in vacuo afforded 2.8 g (85%) of a colorless solid cis-4-fluoro-1- (D) -3-eecappi22-metholpripano [2H] -proline with a melting point of 135-137 °. C (sinters at 129 ° C) e optical rotation '' = -116 ° (c = 1; ι ^^ οΌ ·
Example 5
1- (2-isopropylthio) -12-ylpropapanoyl-l-proline (Isomer A).
1.44 g of L-proline and 667 mg of sodium carbonate were dissolved in 17 ml of water and dissolved. After stirring, it is cooled in ice, and then a solution of 2 g of sodium carbonate in 8.5 ml of water is added, followed immediately by 2.5 g of 3-acetyl-h-o-2-h-halo-o-propanoic acid chloride. Remove the cooling bath. After 30 minutes, a precipitate formed which was dissolved by adding 17 ml of water. After a total of 1.5 hours, the reaction mixture is extracted twice with ethyl acetate, the aqueous layer is cooled, acidified with concentrated hydrochloric acid, saturated with sodium chloride and extracted with ethyl acetate. After drying over magnesium sulphate and concentration in vacuo to dryness,
3.3 g of crude product as an oil.
The oil was applied to a 100 g @ 1 H @ 2 gel column and eluted with 7: 1 benzene / acetic acid. 2 g of product are obtained which, after taryalization from water, yields 450 mg of 1- [3- (acetylhydroxy) -2-trifluoromethyl-4-ol] melting point 111 DEG-113 DEG C. and optical rotation [.alpha.] D = 170. (C = 1; ethane).
Example 6 <sub>:</sub>
- [Зз (acetylthiu) -2-chloropoupanooSl-LpгoUio (isomer · B)
The aqueous mother liquors of Example 5 were lyophilized and purified by chromatography using a 7: 1 mixture of benzene and acetic acid as eluent. The fraction containing the material 10002010, UV light, which, according to the crystallography, is not a thin layer of homunene, was started, concentrated to dryness and the residue crystallized from water. 800 m of compound are obtained at a melting point of 90 to 109 ° C and an optical rotation of -44 ° (c = 2,1-ethhenol). The mother liquors were concentrated to dryness by lyophilization and the residue formed by 1- [3- (acatylhhlo) -2-chloroPOPOPlonoyl] -L-propyl (isomer
B) is crystallized from a mixture of ether and hexane. 380 mg of the product is obtained at a melting point of 108 DEG-110 DEG C. and an optical rotation of +17.6 DEG (c = 1.25; ethanol).
Example 1
1- [3- (ajcetythho) -2-Oromppoopnonyl-11 Lpollin
Substitution of 3-pentylhhlo-β-hlopropanic acid chloride by the procedure of Example 5 with 3pecetylhlo-O-bromopropinic acid chloride yields 1-b- (ietetylthiophthalmol)] - β-γ-11 at a melting point of 109-110 ° C and an optical rotation of [i]. [.alpha.] D = -162 DEG (c = 1.39, ethoxy).
Example
3p (Meihosophobonyl) tU-ot-trSOOmorβetlmrlpolonate acid
A mixture of 3.9 g of 1-trifluoromethyl-acrylic acid and 4.3 g of 4-methyl-4-carbonyloylthols was stirred at 100 DEG to 110 DEG C. for 1 hour, then left to cool to room temperature and solid maltrial. recrystallizes from cyclohexin. The desired product melting at 72-74 ° C is obtained.
EXAMPLE 9 teoc.Oul ^; ^] Lesteo 1- (3- (4-methophpboaoyllthiop2ptrifSuomylehrylpropeooyhJpL)
To a solution of 6.5 g of 3- (4-pmtho) β-carbonyoyl-thiOp 2 -ptrifluoro-pentane and 3.76 g of taoc.Ostyl.asteou proline in 500 ml of dichloromethane is added 4.53 g of dicyclohexylchloride while stirring at 0 ° C. 30 minutes at 0 ° C, then overnight at lithium temperature, filtered and the filtrate was neutralized. The organic layer was dried and concentrated to dryness in vacuo. The ttlikagahs thin layer residue chromatograph in the methylene chloride-ethyl acetate (95: 5) solvent system contains two major spots of Rg 0.46 and 0.51 respectively, corresponding to two iilseoaooi8Paorom ·
Example 1 ad 10 *
- (3-menrkatOv22 · lrlfllVImβt ^ hrlpropotnvlL) -L · ppoVio
A solution of 4.47 g of tert-butyl ester 1- [3- (methylmethoxybenzyl) -2-trifluoromethylchloroethyl] -L-proline prepared in Example 9 and cooled to 0 DEG C. with 10 ml of anisol, and then firstly 100 ml. acid and then 3.18 g of mercuric acetate.
·. The cooling bath was removed, the reaction mixture was stirred at room temperature for hodinu hour, then snapped to dryness in vacuo and the residue triturated with ether / hexane. The insoluble material was suspended in water and hydrogen sulfide was suspended for 10 minutes. The precipitate was filtered off and the filtrate was collected. 1- (Zmerkepto-2-trifluoromethyl-chloroethyl) -L-prolio was obtained as a dark solid, which had a silica gel gel thin layer in a 7: 1 benzene-acetic acid solvent system (7: 1) Rf 0.29- 0.31.
Example tunes 1
Chloride D · 3ltcetyllhVl2l-meUyL0pvopanvové keliny
A suspension of 1 50 g (690 mam) of 1 · 1 (D-3-methyl-2-methyl-2-methyl-1-propanol) 1-roll in 1,274 ml of water and 426 ml (5.526 mol) of concentrated hydrochloric acid was heated under stirring to reflux for 8 hours. reflux condensers *. The resulting solution was allowed to stand overnight at room temperature and then extracted ten times with 400 ml of chloroform.
The combined chloroform extracts were dried under nitrogen over sodium sulfate and evaporated. 176 ml (1.809 mol) of cetane hydride and 180 ml of pyridine were added to the residue of 81.2 g and the mixture was allowed to react at 20 DEG C. for 20 hours and then evaporated.
The oily residue is dissolved in 1000 ml of ethyl acetate, the solution is treated with 200 ml of a saturated solution of sodium chloride containing 5% hydrochloric acid (pH 2), twice with a saturated solution of sodium chloride (the second having a pH of 7). ) and then the solvent is evaporated
96.9 g (86.5%) of a clear, oily residue having an optical rotation of -61.8 DEG (chloroform) are obtained. To this residue was added 83 ml (1.173 mol) of freshly-treated citric acid and the solution was stirred at room temperature for 18 hours while gas evolution occurred.
The supernatant was removed in vacuo at a bath temperature of 50 ° C and distilled under reduced pressure. 55.9 g of D13-tert-ethylthio-1-methylpropionic acid chloride are obtained, boiling at 40 DEG-44 DEG C./23 to 27 Pa, and optical rotation = -42.5 DEG (c = 2; methanol).
Example 12
Tr8aos1- ['D1-Lacetylthio) -2-methyl-11-propyl] -4-fluoro-L-orol
A) Tran8-1lbosyl · vylcycloool·L - fllvrlL-orolio
11.5 ml of 2 N sodium hydroxide solution are added dropwise at 0 to 5 ° C to a solution of 6.2 g of tert-butylbenzylcarbonyl-oxylcarbonyl ester in 50 ml of methanol at 0-5 ° C, the mixture is cooled at 0 ° C for 1 hour and then is allowed to warm to room temperature overnight. The mixture was quenched from reduced pressure to half its original volume, diluted with 100 mL of water, extracted with ether and the ether extracts discarded.
The aqueous solution was acidified to pH 2 with hydrochloric acid while cooling. - the lever is extracted four times with 50 ml of ethyl acetate each time. The ethyl acetate extracts were dried over anhydrous magnesium sulfate and concentrated under reduced pressure.
230 562
194 DEG-196 DEG C. and an optical rotation of -44 DEG (c @ + - .delta.);
The free acid is obtained by passing the cyclohexilammonium salt in 25 ml of ethyl acetate with 22 ml of 1 N hydrochloric acid and extracting the aqueous layer four times with 35 ml of ethyl acetate each time. The combined ethyl acetate extracts were evaporated under reduced pressure without any magnesium sulphide and solvent to give the desired tris-1-ol.<sup><</sup>banzylo: χУcceЪooyl'4 - luoχr> -L-proline.
B) trans-4-fluoro-L-proline tydrobromide
A mixture of 3 g of trana-1-benzlloxycarbonyl) -4-fluoro-L-proline and 15 ml of 30-32% hydrogen bromide in acetic acid was stirred for 1 hour, after which 150 ml of anhydrous ether was added. The solvent is decanted from the precipitate and the precipitate is triturated first with - fresh ether and then with mottylethylketone. There was obtained trans-4-fluoro-L-proline hydrobromide, m.p. 162-164 ° C - (decomposition) and optical rotation [α] -30 ° (c 1 ann methanone).
C) Trans-1- [D-3- (Acatylthio) -2-methyl-1-oxopropyl] -4-fluoro-L-proline
To a solution of 1.9 g of trena-.alpha.-fluoro-L-proline hydrobromide in 25 ml of cold water was added 1 g of sodium carbonate with stirring to adjust the pH to 8.2. 1.8 g of D-3-acetylthio-2-methylpropionyl chloride in 2.5 ml of ether are then added dropwise to the mixture, while cooling at 5 [deg.] C. and stirring, while maintaining the pH at about 8 by dropping a 25% aqueous solution of sodium carbonate. 2 ei 8.3. After the addition was complete, the reaction mixture was stirred with cooling for 1 hour, then extracted twice with 25 ml of ethyl acetate each time, and the extracts were washed with ethyl acetate.
50 ml of ethyl acetate were added to the aqueous layer, and concentrated hydrochloric acid was added dropwise to the mixture with stirring and cooling until pH 2.0. The aqueous layer was saturated with sodium chloride and the ethyl acetate layer was separated. The aqueous layer was extracted three times with 25 ml of ethyl acetate each time, the combined ethyl acetate extracts were taken up in anhydrous magnesium sulfate and concentrated under reduced pressure. The desired product is obtained, which is converted into the dichloro-hexylammonium salt by dissolving in 25 ml of ethyl acetate and adding a solution of 1.8 g of dioiclohexilamine in 35 ml of ethyl acetate.
The precipitated salt was filtered off and recrystallized from isopropyl alcohol. The disidohexylemmonium salt of tris-1- [D-3- (soothyl) -2-methyl-1-oxo-propyl] -4-fluoro-L-proline melting at 209 DEG -211 DEG C., optical rotation [.alpha.] -85 DEG (.alpha. Me Meiemel).
The free acid is regenerated by dissolving the dicidohexylammonium salt in 5% aqueous potassium bisulfate solution and extracting the solution with ethyl acetate. The desired product is obtained
1- [D-3- (acetylthio) -2-methyl-1H-1-oxopropyl] -4-fluoro-L-pgoline
Example 13
Traa8s4-fluoro-1- (D-3-marcapto-2-methyl-1-oxoproppУ) -L-proline
To a cold solution of 4.2 ml of concentrated ammonium hydroxide in 16 ml of water and introduce a stream of argon, and then, under argon atmosphere, add 1.8 & lt; trans-1- [D-3- (α * tlthio)] stirring. 2-Methyl-1-oxo-propyl-4-fluoro-L-proline.
The ethyl acetate extract is discarded, 30 ml of ethyl acetate are added to the aqueous layer, the aqueous layer is treated with concentrated hydrochloric acid, saturated with sodium chloride, and the ethyl acetate layer is separated. The aqueous layer was extracted three times with 30 ml of ethyl acetate, and the combined ethyl acetate extracts were then evaporated<sup>1</sup>Anhydrous magnesium sulphate and suction were allowed to cool to room temperature. The desired trns-4-fluoro-1- [D-3-mercapto-2-methyl-1-oxopropyl] -L-proline is obtained with an optical yield of [α] = -112 ° (c »1%; methanol) .
Example 14
1- [D-3- (acetylthio) 22-methyl-1-oxopropyl] -4,4-difluoro-L-prolio
A) 1-Benzyl-p-β-γ-cyclo-1,4-difluoro-L-poolin
To a cooled solution of 3.3 g of 1-benzyloxleabonol-4-keto-L-proline meecyl ester in 80 ml of n-trichlorodichloride was added dropwise 3.3 ml of methylamifluorofluorifluoride in 80 ml of stirring. The reaction mixture is allowed to stand overnight at room temperature, about 100 g of crushed ice are added while stirring, and the resulting mixture is stirred for 45 minutes. The organic layer was separated and the aqueous layer was extracted twice with 40 ml of meetylene chloride. The combined extract was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. There was thus obtained 1-benzyl-1,4-dioxo-1,4-dihydro-1,4-difluoro-L-methyl-methyl alcohol.
B) 1-Benzyloxycarbonyl-4,44-difluoro-L-proline
To a solution of 5.6 g of 1-benzyl-hexyl-1,4-difluoro-L-proline meethexyl ester in 50 ml of methanol at 0-5 ° C was added dropwise 11.5 ml of 2 N sodium hydroxide solution. The reaction mixture was allowed to react for 1 hour at 0 ° C and allowed to warm to room temperature overnight. The resulting mixture was turned to about half its original volume under reduced pressure, diluted with 100 mL of water, extracted with ether and discarded the ether extract. The aqueous solution was acidified with dilute hydrochloric acid to pH 2 from cooling and extracted three times with 50 ml of ethyl acetate each time.
The bitylacetate extract was combined, washed with saturated aqueous sodium chloride, dried over anhydrous magnesium sulfate, and then bent. The desired 1-beozyloxycarbonyl-4,4-difluoro-L-prolio is obtained, which salt is converted to the cyclohexylemmonium salt. The product has a melting point of 180-185 ° C and an optical rotation of = -24 ° (c = 1%; ethanol).
The free acid is obtained by adding hydrochloric acid to an aqueous solution of the cyclohexylsonic acid salt and extracting the mixture four times with 30 ml of haloacetate. The ethyl acetate extract was dried over anhydrous magnesium sulphate and bent under reduced pressure. The desired t-beosyl-4-cyclooyl-4,44 difluoro-L-prolio is obtained.
C) 4,4-difloo-L-pouline hydrobromide
A mixture of 2.4 g of 1-benzylcarbonyl-4,44-fluoro-L-prulia and 12 ml of 30 to 32% hydrogen bromide in acetic acid was stirred at room temperature for 30 minutes and then 300 ml of anhydrous ether was added. The resulting mixture was cooled, the precipitate formed was decanted and dried under reduced printing. The desired 4,4-difluoro-L-poolin hydrobromide melts with decomposition at 163-165 ° C, with an optical rotation of [α] = -14 ° (c = 1%; methanoo).
D) 1-D-3- (acetyl, hio) 22-ultlyl-1-oxuprupyl-4-di-1H-l-prolio
To a solution of 2.7 g of 4,4-fluoro-L-poolin hydrobromide in 30 ml of water cooled to 5 ° C was added solid sodium carbonate up to a pH of 8.4 and then mixed under constant cooling. and stirring dropwise 2.4 g of D-3-acetyl-thio-2-methylpiperfooyl chloride in 3 ml of anhydrous ether, maintaining the pH of the solution at 8.1 to 8.3 by adding 25% aqueous sodium carbonate solution. After the addition was complete, the reaction mixture was stirred under cooling for an hour, then extracted twice with 25 ml of ethyl acetate and the extract. is postponed. Ethyl acetate (50 ml) was added to the aqueous layer, and concentrated hydrochloric acid was added dropwise with stirring and cooling to pH 2.0.
0 562
The aqueous layer was saturated with sodium chloride and the ethyl acetate layer was separated. The aqueous layer is extracted three more times with 25 ml of ethyl acetate each time, the combined ethyl acetate extracts are dried over anhydrous magnesium sulphate and concentrated under reduced pressure. The desired product is obtained which is converted into the dicyclohexylammonium salt by dissolving in 40 ml of ethyl acetate and adding a solution of 2.3 g of dicyclohexylamine in 5 ml of ethyl acetate.
The precipitated salt is filtered off and recrystallized from ethanol. The dicyclohexylammonium salt of 1- [D-33 (ethylthio) -2-methyl-1-oxoppropyl] -4,4-difluoro-L-proline melts at 225-227 ° C and has an optical rotation of [α] = -70 ° (c = 0.5%;
The free acid is regenerated by dissolving the dicyclohexylammonium salt in 5% aqueous potassium bisulfate and extracting with ethyl acetate. The ethyl acetate extract was dried over anhydrous magnesium sulphate and curved under reduced pressure. The desired 1- [D334 (acetylthoo (22-methyl-1-isoxropropS) -3,4-difluoro-L-proline) was obtained.
Example 1 · 1 5
4,4-Difluoro-1- (D-3-mercapto323methyl-1-oxopropyl) -L-proline
To a cold solution of concentrated ammonium hydroxide (4.6 ml) in water (11 ml) was added a stream of argon, and 2.1 g of 1-fD-1- (4-acetylthio) 2-methoxys-1-oxoopooylS-3,443ffluprзL was added under stirring in an argon atmosphere. The reaction mixture was stirred for a further 2 hours and then extracted with ethyl acetate.
The extract was discarded, 30 ml of ethyl acetate were added to the aqueous layer with stirring, the aqueous layer was acidified with concentrated hydrochloric acid, saturated with sodium chloride and the ethyl acetate layer was separated. The aqueous phase is extracted three times with 25 ml of ethyl acetate each time, the combined ethyl acetate extracts are dried over anhydrous magnesium sulphate and concentrated under reduced pressure. The desired 4,4зfifSuoз - (- (DзЗ-merkeptpз2зmethylз1зpχoprooyS) -L-proline in the form of a syrup is obtained, with an optical rotation of [α] = -85 ° (<sub>C</sub> = 1 ·· methane!).
Example 16
Ciu-4зchlprз1- (3-aceSythiPз23-D-methylprppanopS) -L-prolio
3.15 g of cis-4-chloro-4-chlorophenol bromide are treated with 2.8 g of D-3-acetylthiP-2-methylpropionyl chloride in 40 ml of water containing 2.3 g of sodium carbonate (the acid chloride is first dissolved in 4 ml of ether) . The mixture was maintained for 10 minutes by the addition of 8 ml of 25% sodium carbonate solution at pH 8.2 to 8.4.
The resulting mixture was stirred for an additional hour, after which the product was extracted with ethyl acetate to give 3.6 g of a viscous oily material which was converted into ethyl acetate.<sup>E</sup> dicyclohexylemine salt, rotating at <sup>189</sup> and<sup>192</sup> Noc: 2 ° C <sup>(</sup>sinters when <sup>185</sup> ° C). After recrystallization from isopropyl alcohol, the melting point was increased to 190-192 ° C (sintered at 188 ° C).
Example 17
Ci8з4зchlpr41 4 (3-merkeptoз2зD-meethSpгooeeopSl-LLзroPlo
1.6 g of the product of Example 16 ee by hydrolysis in 9 ml of water containing 4 ml of concentrated ammonium hydroxide are converted to 1.2 g of the desired product which, after trituration with hexane, yields 1.1 g of a colorless solid, m.p. 138-140 ° C. and the optical rotation Mjj<sup>6</sup> = -79 ° (c = 11%; ethane!) ·
4 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4
45 members in 32 offices
Priority claims12
| Document | Office | Kind | Date |
|---|---|---|---|
| 87903278 | United States of America | A | |
| 87903278 | United States of America | A | |
| 93914778 | United States of America | A | |
| 93914778 | United States of America | A | |
| 93914878 | United States of America | A | |
| 93914878 | United States of America | A | |
| 78879032 | – | – | – |
| 78939147 | – | – | – |
| 78939148 | – | – | – |
| US19780879032 | – | – | – |
| US19780939147 | – | – | – |
| US19780939148 | – | – | – |
Members45
| Document | Office | Kind | |
|---|---|---|---|
| PT69254A | Portugal | A | |
| IT7948755A0 | Italy | A0 | |
| US4154935A | United States of America | A | |
| IL56662A0 | Israel | A0 | |
| LU80946A1 | Luxembourg | A1 | |
| BE874345A | Belgium | A | |
| IE790297L | Ireland | L | |
| DK73379A | Denmark | A | |
| FI790593A | Finland | A | |
| NO790568L | Norway | L | |
| SE7901510L | Sweden | L | |
| DE2906768A1 | Germany | A1 | |
| NL7901319A | Netherlands (Kingdom of the) | A | |
| AU4422679A | Australia | A | |
| GB2014987A | United Kingdom | A | |
| FR2417499A1 | France | A1 | |
| JPS54125656A | Japan | A | |
| ES479832A1 | Spain | A1 | |
| ES479833A1 | Spain | A1 | |
| PL213593A1 | Poland | A1 | |
| ES477878A1 | Spain | A1 | |
| DD141827A5 | German Democratic Republic (until 1990) | A5 | |
| ZA79612B | South Africa | B | |
| US4241076A | United States of America | A | |
| RO77228A | Romania | A | |
| PL118158B1 | Poland | B1 | |
| AU518847B2 | Australia | B2 | |
| SU882409A3 | Soviet Union (until 1991) | A3 | |
| NZ189626A | New Zealand | A | |
| CA1124723A | Canada | A | |
| FR2417499B1 | France | B1 | |
| GB2014987B | United Kingdom | B | |
| PH15381A | Philippines | A | |
| AR228036A1 | Argentina | A1 | |
| AR229152A1 | Argentina | A1 | |
| HK41383A | Hong Kong, China | A | |
| CH639370A5 | Switzerland | A5 | |
| SE431643B | Sweden | B | |
| IE47971B1 | Ireland | B1 | |
| CS230562B2This record | Czechoslovakia (until 1993) | B2 | |
| ATA135279A | Austria | A | |
| GR82336B | Greece | B | |
| AT377981B | Austria | B | |
| IT1116497B | Italy | B | |
| JPH0134986B2 | Japan | B2 |
Numbers
- Publication, DOCDB
- 230562
- Publication, EPODOC
- CS230562
- Application
- 791134
- Application, DOCDB
- 113479
- Application, EPODOC
- CS19790001134
Titles
- English
- PRODUCTION METHOD OF HALOGEN N-/MEPKAPTOACYL/PROLINE DERIVATIVES
Classification
- CPC, 5
- C07D211/60
- C07C57/52
- C07C327/00
- C07D207/16
- A61P9/12
- IPC, 11
- A61K31 40
- C07D207 12
- A61K31 401
- A61K31 445
- A61P9 12
- C07C57 52
- C07D207 10
- C07D207 16
- C07D211 36
- C07D211 38
- C07D211 60
